BioSpace News Archive

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2022 financial results on Wednesday, October 26, 2022, prior to the market open.

RadioMedix, Inc., a clinical-stage biotechnology company announced an agreement with an entity related to Portland Investment Counsel Inc. involving an equity investment of $40 million Series A funding round.

At the 37th Society for Immunotherapy of Cancer Annual Meeting (SITC 2022), set to take place on November 8-12, 2022, in Boston, Massachusetts (United States), via in person/virtual attendance, Antengene will release data from preclinical studies of four pipeline assets, ATG-031, ATG-101, ATG-018, and ATG-027, in one oral presentation and three poster presentations.

Cardiac Imaging Associates (“CIA”) is notifying certain individuals of a recent data privacy incident that may impact the privacy of a limited amount of information.

ORIC Pharmaceuticals, Inc. announced that on October 3, 2022, ORIC granted a total of 116,560 non-qualified stock options and 19,435 restricted stock units to five new non-executive employees who began their employment with ORIC in September 2022.

Sensient Technologies Corporation will hold its conference call to discuss 2022 third quarter results at 8:30 a.m. CDT on Friday, October 21, 2022.

XORTX Therapeutics Inc. announces the closing of an underwritten public offering of: 1,400,000 common share units, with each Common Share Unit consisting of one common share, no par value, and one warrant to purchase one common share at a public offering price of US$1.00 per Common Share Unit.